AI seizure prediction wearable market seen reaching $3.87 billion by 2030

The artificial intelligence-powered seizure prediction wearable market is projected to grow from $1.73 billion in 2026 to $3.87 billion by 2030, as demand rises for real-time seizure alerts, remote neurology care and AI-driven monitoring. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Artificial intelligence-powered seizure prediction wearables are designed to detect likely epileptic seizures earlier, which can improve patient safety and quality of life. - The market’s projected expansion signals growing demand for tools that move epilepsy care beyond traditional monitoring. - Rising neurological disorders are adding urgency to early-detection technology.

What happened: - The Business Research Company released a report on the artificial intelligence-powered seizure prediction wearable market covering 2026 through 2035. - The market is projected to rise from $1.41 billion in 2025 to $1.73 billion in 2026. - The report forecasts the market will reach $3.87 billion by 2030. - The forecast implies a 22.3% compound annual growth rate through 2030.

The details: - The historical growth rate from 2025 to 2026 is 22.5%. - Growth is linked to the rising prevalence of epilepsy, advances in wearable biosensors, demand for early seizure detection, limits in traditional monitoring methods and higher neurological research activity. - The wearables combine advanced sensors with AI algorithms that continuously track physiological signals. - The devices analyze data in real time and can alert users about an impending epileptic seizure. - The report says future growth will be supported by better AI predictive accuracy, expansion of remote neurology services, stronger demand for real-time seizure alerts, integration with mobile health apps and patient-centered epilepsy care. - Emerging trends include predictive detection of neurological events, continuous EEG monitoring through wearables, personalized seizure alert systems, AI-driven recognition of seizure risk patterns and more home-based epilepsy care. - The report also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - A free sample is available here: Download a free sample. - The full report is available here: View the full report.

Between the lines: - The report points to a broader shift in neurological care toward continuous, AI-assisted monitoring outside clinical settings. - The focus on mobile health integration and home-based care suggests vendors are targeting patients who need more timely alerts without constant hospital supervision. - North America led the market in 2025, but the fastest growth is expected in Asia-Pacific, indicating the technology is still early in global adoption. - A cited April 2024 National Library of Medicine estimate said about 6.9 million Americans age 65 and older were living with Alzheimer’s dementia, with that figure expected to nearly double to 13.8 million by 2060, underscoring the broader burden of neurological disease.

What's next: - The market is expected to keep scaling as predictive accuracy improves and wearables become more connected to digital health systems. - Asia-Pacific is expected to post the fastest growth over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says additional 2026 report features include updated graphics, trend analysis and forecasting tools.